Combination Therapy Using Pemafibrate and Dapagliflozin for Metabolic Dysfunction-associated Fatty Liver Disease

Metabolic syndrome, including diabetes mellitus, obesity, and dyslipidemia, is associated with the development and progression of metabolic dysfunction-associated fatty liver disease. Therapeutic strategies, particularly optimal medical therapies, for treating metabolic dysfunction-associated fatty...

Descripción completa

Detalles Bibliográficos
Autores principales: Imamura, Teruhiko, Kinugawa, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208770/
https://www.ncbi.nlm.nih.gov/pubmed/36198591
http://dx.doi.org/10.2169/internalmedicine.0277-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208770/
https://www.ncbi.nlm.nih.gov/pubmed/36198591
http://dx.doi.org/10.2169/internalmedicine.0277-22

Ejemplares similares